Top Markets
#1 Audiera Audiera +35.09%
#2 GALA GALA +33.70%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.94%
#4 Bitcoin Cash Bitcoin Cash +32.75%
#5 Fabric Protocol Fabric Protocol +32.18%
#6 Tutorial Tutorial +30.33%
#7 Zora Zora +29.59%
#8 Bless Bless +29.29%
#9 Arowana Arowana +28.17%
#10 Pepe Pepe +26.40%
Coin of the day
Audiera Audiera
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Clasificación en acciones #24577
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Precio por acción
$1.48
Última sincronización: 2025-03-24
Capitalización bursátil
$59.05M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
GB
Comercio Achilles Therapeutics plc (ACHL)

Categoría

Healthcare
Ganancias de Achilles Therapeutics plc (ACHL)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Achilles Therapeutics plc, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Achilles Therapeutics plc desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH